Business Standard

Fermenta Biotech standalone net profit declines 6.20% in the March 2022 quarter

Image

Capital Market

Sales rise 4.14% to Rs 94.66 crore

Net profit of Fermenta Biotech declined 6.20% to Rs 9.07 crore in the quarter ended March 2022 as against Rs 9.67 crore during the previous quarter ended March 2021. Sales rose 4.14% to Rs 94.66 crore in the quarter ended March 2022 as against Rs 90.90 crore during the previous quarter ended March 2021.

For the full year,net profit declined 41.81% to Rs 30.24 crore in the year ended March 2022 as against Rs 51.97 crore during the previous year ended March 2021. Sales rose 4.06% to Rs 387.96 crore in the year ended March 2022 as against Rs 372.82 crore during the previous year ended March 2021.

 
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales94.6690.90 4 387.96372.82 4 OPM %19.6119.87 -19.5725.14 - PBDT17.0516.78 2 66.2482.26 -19 PBT11.0210.84 2 42.5763.23 -33 NP9.079.67 -6 30.2451.97 -42

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: May 30 2022 | 4:56 PM IST

Explore News